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Abstract 
 
Purpose:  This cross-sectional, correlational study was conducted to examine the associations 
between engagement in the patient-provider relationship and quality of life and adherence 
among persons living with HIV/AIDS. The project is a sub-study of an international, multi-site 
study examining the adequacy of a self-care symptom management model that hypothesizes 
relationships among person, illness representation, symptom self-care, perceived effectiveness 
of self-care activities, adherence, and outcomes appraisal in a large, HIV-positive sample 
(n=1072). Method:  A convenience sample of non-hospitalized persons receiving care at The 
Ohio State University Infectious Diseases Outpatient Clinic and Children’s Hospital Family AIDS 
Clinic and Educational Services was recruited from May to November, 2003. IRB approval was 
obtained from each of the participating sites. A 35-page survey was administered to subjects 
qualifying for the study who provided informed consent. Subjects received $20 for completing 
the questionnaire. All measures were self-report. Demographic data gathered included gender, 
age, race/ethnicity, length of HIV diagnosis, and presence of AIDS diagnosis. The sample 
included 57 persons living with HIV/AIDS with a mean age of 40 years, of which 28% were 
women and 58% were white; the mean length of HIV diagnosis was 10 years and 39% had an 
AIDS diagnosis. Engagement was measured using the 13-item Engagement with Health Care 
Provider scale. The HIV/AIDS Targeted-Quality of Life scale, a 42-item HIV-specific instrument, 
was used to measure the following nine dimensions of quality of life: overall function, life 
satisfaction, health worries, financial worries, medication worries, HIV mastery, disclosure 
worries, provider trust, and sexual function. Adherence, an assessment of compliance with 
provider advice and medication regimen, was measured with the 5-item Advice and Instruction 
scale and the 15-item AIDS Clinical Trials Group (ACTG) Reasons for Nonadherence to 
Medications checklist, respectively.  Findings:  Better quality of life was found to be significantly 
related to engagement with health care provider (p=0.013) as was adherence to provider advice 
(p=0.001). While positively correlated, no statistically significant relationship was found between 
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engagement and adherence to medication.  Implications: Results of this study support existing 
literature suggesting a positive association between increased engagement with health care 
provider and better quality of life among persons living with HIV/AIDS. A limitation of the study, 
particularly in regard to adherence, is the self-report design. Nevertheless, the study does 
suggest the need to develop and promote strategies that foster a healthy patient-provider 
relationship in this population to improve quality of life and adherence to treatment. 
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 Associations Between Engagement in the Patient-Provider  
Relationship and Quality of Life and Adherence Among 
Persons Living with HIV/AIDS 
 The HIV/AIDS epidemic has had devastating effects on American society since its 
beginning in the 1980s. According to reports from the Centers for Disease Control and 
Prevention (www.cdc.gov, n.d.), between 800,000-900,000 people are currently living with 
HIV/AIDS in the United States, with 40,000 new cases diagnosed each year. As of December 
2000, there have been 448,860 AIDS-related deaths. These statistics may well be an 
underestimation of the problem, as they do not represent unreported cases. 
 HIV/AIDS presents countless challenges to those suffering from the disease. Complex 
medication schedules with adverse side effects (Reynolds, Neidig & Brashers, 1999), negative 
social stigmas (Robinson, 1998), and the eventual decline in immune function are just a few of 
the challenges faced by people living with HIV/AIDS. However, with the advent and relative 
success of antiretroviral (ARV) therapy in the mid-late 1990s, more people infected with HIV are 
living longer, healthier lives (Roberts, 2002). Active self-management is necessary for the 
patient to actualize the benefits of adherence to therapeutic regimens. Furthermore, the 
importance of quality of life becomes more salient to patients realizing that they have a chronic 
disease to manage for what could be a relatively long life (Holzemer, Spicer, Wilson, 
Kemppainen & Coleman, 1998). 
As a result of advancements in treatment, HIV/AIDS has evolved from a lethal disease to 
a chronic one that requires regular interaction between patient and health care provider (Vogl et 
al., 1999). The literature suggests that the nature of the patient-provider relationship plays a role 
in patient outcomes among people living with HIV/AIDS. Because health care providers were 
not immune to the extreme negative social stigma associated with HIV/AIDS at the onset of the 
epidemic, many nurses experienced fear of becoming infected (Burr, 1996; Peate, 1995) and 
homophobia (Rose, 1994; Taylor & Robertson, 1994), feelings that consequently affected the 
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care they provided (van Wissen & Woodman, 1994). Such feelings by the health care provider 
were often short-lived as prognosis for the disease was poor and death directly imminent. 
However, the increased life expectancy of HIV/AIDS patients warrants health care workers to be 
more involved in the care of these patients for longer periods of time, thereby making the 
relationship even more critical in patient outcomes (Ickovics & Meisler, 1997; Singh, Squier, 
Sivek, Wagener, Nguyen & Yu, 1996). 
 The ramifications of the change in the disease affect both patients and providers, as well 
as the interaction between the two. The nature of the interaction can result in greater patient 
satisfaction and adherence or have the reverse effect, depending on how patients perceive the 
interaction (Roberts, 2002). Moreover, providers are faced with providing long-term care for a 
socially stigmatized population, while patients must manage a complex disease in addition to 
coping with social stigmas. Research is needed to examine the extent of these ramifications on 
patient outcomes as they relate to adherence and quality of life in people living with HIV/AIDS. 
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Review of Literature 
Adherence 
 The research related to adherence to therapeutic regimens in HIV/AIDS patients has 
been extensive. Much of this research addresses adherence to ARV medications. 
 The benefits of ARV medications are remarkable in their effect on the progression of 
HIV. If taken correctly, ARV medications have the potential to reduce viral load below the level 
of detection in some patients; in turn, there is the possibility of slow recovery of immune function 
(Holzemer et al., 1999; McPherson-Baker, Malow, Penedo, Jones, Schneiderman & Klimas, 
2000). Conversely, non-adherence is dangerous because the patient can potentially develop 
resistance to ARV medications. Recent evidence suggests that even 80% adherence to ARV 
therapy can lead to resistance (Holzemer et al., 1999). Further, Blaschke (1997) found evidence 
of increasing viral load after patients missed only two days of medication.  
 Reports of non-adherence to ARV medications vary across studies. A cross-sectional 
study of 52 HIV-positive men and women found that 58% were non-adherent to their prescribed 
regimens (Muma, Ross, Parcel & Pollard, 1995). A similar study reported that 50% of 
participants were non-adherent (Chow, Chin, Fong & Bendayan, 1993). Further reports have 
suggested a range of adherence from 20-80% among various populations (Chesney, 1997). 
 The literature supports an interplay of numerous variables in adherence among 
HIV/AIDS patients. Holzemer et al. (1999) identified forgetfulness, lack of information, symptom 
side effects, treatment fatigue, and lack of social support as a few of the variables leading to 
poor adherence.  
The presence of distressing symptoms is a correlate of non-adherence that has been 
identified by several researchers. Fontaine and colleagues (1999) conducted a multicenter, 
cross-sectional study of 118 hospitalized and 172 ambulatory HIV patients and their physicians 
in France to assess physicians’ reported recognition of symptoms reported by patients. Fatigue 
was the symptom most often identified by both hospitalized and ambulatory patients at 77% and 
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72% respectively. Sleep problems and anxiety were also highly reported with 62% and 51% of 
hospitalized and ambulatory patients reporting sleep problems respectively, and 64% and 63% 
of hospitalized and ambulatory patients reporting anxiety respectively.  
Other research suggests that much of the intolerance to ARV therapy is due to 
treatment-related symptoms (Melbourne, Abbaticola, Rana & Fisher, 1998). Of the 74 HIV-
positive patients in this study, 32 reported intolerance as the primary reason (81%) for 
discontinuing their medication. Those who were intolerant had significantly higher incidences of 
the following symptoms than the tolerant group: nausea, 73% vs. 30%; vomiting, 50% vs.14%; 
and diarrhea, 54% vs. 46%.  
Holzemer et al. (1999) examined the relationships between the five dimensions of a 
health-related quality of life model and self-reported adherence to medication, provider advice, 
and medical appointments in people living with HIV. A convenience sample (n=420) of HIV-
infected men and women recruited from seven cities across the United States yielded results of 
higher symptom scores, particularly depression, being correlated with increased likelihood of 
non-adherence to medication, provider advice, and to miss health-related appointments. 
These studies illustrate the importance of adherence in managing and controlling 
HIV/AIDS. Moreover, they lend support to the necessity of first identifying factors that contribute 
to non-adherence in order to implement the most beneficial interventions to promote adherence. 
Quality of Life 
Quality of life encompasses numerous facets of life and has been defined as a 
“multidimensional construct” (Vogl et al., 1999, p.254). The success of ARV medication also has 
implications for quality of life issues in people living with HIV/AIDS. Further, quality of life has 
become of greater concern with the growing acceptance of HIV/AIDS as a chronic disease.  
The presence of symptoms related to the disease and its treatment has been proposed 
as the strongest indicator of impaired global quality of life in HIV-positive patients (Wachtel, 
Piette, Mor, Stein, Fleishman & Carpenter, 1992). In a sample of 42 HIV-infected women, 
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Israelski and colleagues (1998) found that greater total number of HIV symptoms was 
associated with decreased quality of life. Wachtel and colleagues (1992) found that in a sample 
of 520 HIV-infected patients, 72% reported neurological symptoms, 69% reported constitutional 
symptoms, 50% reported dyspnea, and 47% reported diarrhea. The presence of multiple 
symptoms was correlated with a lower quality of life in this study. 
Other studies have focused on determining what factors truly represent quality of life in 
HIV/AIDS patients. The Living with HIV scale was developed to measure the quality of life of 
people living with HIV/AIDS (Holzemer et al., 1998). This 38-item scale was developed from the 
grounded theory, Salvaging Quality of Life (Wilson, Hutchinson & Holzemer, 1997). The theory 
was generated from interviews with a sample of Hispanic, Anglo-American, and African-
Americans (n=38) and family/significant-other caregivers (n=10) and from six focus groups with 
expert nurse clinicians in the field of HIV/AIDS care (n=30). The instrument identifies the 
following nine domains of quality of life: avoiding the fear zone, loss, body image, juggling 
treatments and side effects, independence, death calculations, cherishing the environment, 
coveting time, and resolving spiritual issues. Using this scale, Holzemer et al. (1999) found that 
patients who viewed themselves positively on cherishing the environment also reported greater 
adherence and were more likely to follow advice. 
Similar to the Living with HIV scale, the HIV/AIDS Targeted- Quality of Life instrument 
(HAT-QoL) identifies nine dimensions of quality of life: overall function, life satisfaction, health 
worries, financial worries, medication worries, HIV mastery, disclosure worries, provider trust, 
and sexual function (Holmes & Shea, 1998). Again, item content for this 42-item instrument was 
determined from interviews with a sample of HIV-positive individuals (n=243). 
Research on quality of life in people living with HIV/AIDS is often problematic as a 
standardized measurement still eludes researchers. However, the research to date suggests 
that a variety of physical, psychological, and social factors must all be considered when 
addressing quality of life issues. 
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Patient-Provider Relationship 
As with other chronic diseases, the patient-provider relationship plays a critical role in 
patient outcome within the HIV/AIDS population (Bakken et al., 2000; McPherson-Baker et al., 
2000; Pearson & Raeke, 2000). According to Robinson (1998), patient satisfaction with health 
care is a primary outcome measure of quality of care.  
Kelly and colleagues (1988) reported that nurses, as members of society, cannot avoid 
being swayed by the social issues that affect public attitudes towards HIV/AIDS. Negative 
attitudes towards people with HIV/AIDS may affect the quality of patient care or even result in 
refusal to care for these patients (Frank, 1986; Gerbert, Macguire, Badner, Altman & Stone, 
1988). Those who do reluctantly care for HIV/AIDS patients often cause the patient to act 
defensively and be uncooperative. Kemppainen and colleagues (1998), in a qualitative study of 
118 men and women with HIV/AIDS, noted that patients’ behaviors were directly related to the 
nurse-patient interaction. Meaning, if patients perceived their nurse as disrespectful, they would 
reciprocate the disrespect toward the nurse. In this regard, the nature of the interaction between 
patient and provider becomes critical in maintaining a trusting environment.  
Furthermore, the patient-provider relationship has been proposed as an important factor 
in adherence. Holzemer et al. (1999) found that in an HIV-positive sample, patients with more 
engagement with providers were more likely to follow the provider’s advice. Although not 
statistically significant, engagement was also negatively correlated with number of missed 
appointments. However, the broad category of “interpersonal environment”, which included 
engagement, caring, and social support, did show a significant relationship (p < 0.03) with 
number of missed appointments. In an experimental study of HIV-positive men (n=42), 
McPherson-Baker et al. (2000) found that a 5-month medication counseling intervention led to 
an increase in adherence in the experimental group. The researchers identified the increased 
opportunity for interaction between participant and health care provider as a strength of the 
intervention, a hypothesis supported by Muma et al. (1995).  
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Further research has shown the importance of trust in the patient-provider relationship. 
Thom and Campbell (1997) conducted focus groups with 29 patients, asking them to recount 
specific incidences that had influenced their trust in their providers. Results from this study were 
consistent with the literature in that trust in the provider increased the likelihood of subjects’ 
adherence to treatment recommendations. Another qualitative study, including 28 HIV-positive 
patients, found that patients reported that they would be less likely to trust and take ARV 
medications if they did not trust their provider (Roberts, 2002). 
A healthy patient-provider relationship can also positively influence quality of life 
outcomes in those living with HIV/AIDS. A descriptive, correlational study of 707 ambulatory 
persons living with HIV/AIDS determined that patients who reported more engagement with their 
health care providers also reported significantly greater quality of life and adherence (Bakken et 
al., 2000). 
The literature supports the assumption that a supportive patient-provider relationship can 
have a positive effect on health outcomes in HIV/AIDS patients.  
While extensive research has been conducted examining adherence and quality of life 
issues in the HIV/AIDS population, few studies directly address the role of the patient-provider 
relationship in these areas. More research is needed in this specific area to explore the extent to 
which the patient-provider relationship is involved in patient outcomes. This study aims to add to 
the existing literature. 
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Methods 
Design 
 The purpose of this study is to examine the association between engagement in the 
patient-provider relationship and quality of life and adherence to medication and provider advice 
in persons living with HIV/AIDS. This is a sub-study of an international, multi-site study 
examining the adequacy of a self-care symptom management model that hypothesizes 
relationships among person, illness representation, symptom self-care, perceived effectiveness 
of self-care activities, adherence, and outcomes appraisal in representing an HIV-positive 
sample. A cross-sectional, correlational survey design was used to answer the following 
research questions: 
1. What is the association between engagement in the patient-provider relationship and 
the self-reported quality of life in persons living with HIV/AIDS? 
2. What is the association between engagement in the patient-provider relationship and 
self-reported adherence to medication in persons living with HIV/AIDS? 
3. What is the association between engagement in the patient-provider relationship and 
self-reported adherence to provider advice in persons living with HIV/AIDS? 
Sample 
 The target population for this study was adult males and females living with HIV/AIDS in 
the greater Columbus, Ohio area. A convenience sample was obtained from The Ohio State 
University Infectious Diseases Outpatient Clinic and the Children’s Hospital Family AIDS Clinic 
and Educational Services. Inclusion criteria were: 1) male or female, 18 years of age and older; 
2) English speaking; 3) HIV-positive; 4) able and willing to provide informed consent. There 
were no exclusion criteria related to ethnicity, gender, severity of disease, or presence of other 
co-morbidities other than not meeting inclusion criteria. 
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Procedure 
 The study was approved by The Ohio State University Behavioral and Social Sciences 
Institutional Review Board (IRB) and the Children’s Hospital IRB for the protection of human 
subjects. 
 To recruit for the study, the researcher placed a flyer in the OSU Infectious Diseases 
outpatient clinic and Children’s Hospital, inviting patients to participate in the study. The 
researcher visited the clinic weekly to meet with potential participants during their regular clinic 
appointment. During the meeting, the purpose of the study was explained, at which point, if the 
subject wished to participate and met the inclusion criteria, informed consent was obtained. The 
Rapid Estimate of Adult Literacy in Medicine (REALM) was used to assess the subject’s ability 
to read common medical words and to determine the subject’s ability to complete the 
questionnaire independently. Subjects unable to read at the sixth grade level received 
assistance from the researcher.  Upon completion of the questionnaire, which contained no 
identifying information, subjects placed the survey in a sealed envelope and received $20 as a 
thank-you for their time. Informed consent forms were locked in a file drawer separate from 
completed surveys so that there was no way to identify participants with their surveys. 
Instruments 
 The 35-page survey contains several instruments measuring various aspects of HIV 
symptom management. The larger study will examine all of the data collected; however, this 
study only analyzed subjects’ responses to demographic/individual characteristics, patient-
provider relationship, perceived quality of life, and adherence to medications. Table 1 provides 
an overview of this study’s variables and the instruments used to measure each. 
Demographic questionnaire. A set of demographic questions, including age, gender, 
race/ethnicity, length of time known to be HIV-positive, and presence of AIDS diagnosis were 
used to describe the sample. Age refers to the number of years of life. Gender refers to 
subjects’ identification as either male or female. Race/ethnicity refers to membership in a self-
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identified ethnic group. Length of time known to be HIV-positive refers to the number of years, 
or months, subjects have known about their HIV-positive status. AIDS diagnosis refers to 
whether or not subjects have ever been diagnosed with AIDS.   
Engagement with Health Care Provider. Engagement with health care provider is one 
component of the patient-provider relationship. This variable is conceptualized as “including 
dimensions of access to health care provider, information sharing, involvement of client in 
decision making and self-care activities, respect and support of the provider for the client’s 
choices, and management of client concerns” (Bakken et al., 2000, p.190). Engagement was 
measured using the Engagement with Health Care Provider Scale. This is a 13-item scale 
requiring subjects to rate the nature of their interactions with their primary health care provider, 
be that person a doctor, nurse practitioner, or physician assistant. The rating is based on a four-
point Likert scale, ranging from 1 “always true” to 4 “never true”, with 0 representing “not 
applicable” added for this study. Sample questions include the extent to which subjects feel their 
health care provider listens to them, cares about them, involves them in decisions, and respects 
them. Total scores can range from 0 to 52, with lower scores indicating more engagement with 
health care provider. 
 The scale was developed by Bakken et al. (2000) for initial use in a descriptive study 
(n=707) exploring the relationship between HIV/AIDS patients’ perception of engagement with 
health care provider and demographic characteristics, health status, and adherence to 
therapeutic regimen. The scale was submitted to a principal components factor analysis with 
Varimax rotation. A one-factor solution emerged with an Eigenvalue of 8.6 and 66.5% of the 
variance explained. Cronbach’s alpha reliability estimate was 0.96. 
Advice and Instruction. Adherence to advice and instruction refers to how well subjects 
comply with provider advice and was measured using the Advice and Instruction scale. This 5-
item scale asks subjects if they have difficulty following their health care provider’s advice, have 
followed advice, the importance of the advice, what the health care provider expects, and what 
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family/friends think about the advice. Scores on each question range from 1 to 4 for a total score 
range of 5 to 20. Two items, difficulty following advice and importance of advice, are reversed 
scored, so that the lower the total score for all items, the more adherent the subject is to medical 
advice.  
Holzemer et al. (1999) developed the scale for use in a study examining the 
relationships between the five dimensions of a health-related quality of life model and self-
reported adherence to medication, provider advice, and medical appointments in people living 
with HIV. The instrument was tested for the study in a convenience sample (n=420) of HIV-
infected men and women at various sites in seven cities across the United States to enhance 
external validity. Cronbach’s alpha reliability estimate was modest at 0.61, but determined to be 
adequate. 
HIV/AIDS Targeted- Quality of Life (HAT-QoL). Quality of life encompasses numerous 
facets of life and has been defined as a “multidimensional construct” (Vogl et al., 1999, p.254). It 
was measured using the HAT-QoL instrument. This 42-item HIV-specific instrument assesses 
the following nine dimensions of quality of life: overall function, life satisfaction, health worries, 
financial worries, medication worries, HIV mastery, disclosure worries, provider trust, and sexual 
function. All dimensions are scored so that the final dimension score is transformed to a linear 0 
to 100 scale. However, for this study, the raw final score was used to facilitate data analysis. 
Therefore, scores could range from 0 to 136, where higher scores indicate better functioning. 
The instrument was developed by Holmes and Shea (1998). Group discussions from a 
sample of HIV-positive individuals (n=42) were used to generate initial item content for the 
instrument. Results from this first study yielded a 76-item instrument. A second, cross-sectional 
study was then performed with HIV-positive individuals (n=201) to identify dimensions and 
reduce the number of items. Cronbach’s alpha reliability estimate was = 0.70 for all dimensions, 
except HIV mastery (0.57), medication concerns (0.51), and sexual function (0.56). 
Multitrait/multiitem assessment indicated correct correlations (= 91%) for eight of the nine 
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dimensions. HIV mastery revealed a lower success rate of 79%. Construct validity was 
determined through various self-reported HIV disease markers and self-reported 
sociodemographic variables.  
AIDS Clinical Trials Group (ACTG) Reasons for Non-Adherence to Medications. 
According to Holzemer et al. (1999), medication adherence, and consequently, non-adherence, 
is defined as it is measured. Non-adherence was measured using the ACTG Reasons for Non-
Adherence to Medications, which is a 15-item checklist of reasons patients may not take 
medications as prescribed. The more items that are checked, the more likely an individual is to 
be non-adherent to their medication regimen. 
Data Analyses 
 The sample is described using univariate descriptive statistics including frequency, 
percentage, mean, range, and standard deviation as appropriate. 
 Pearson’s correlations were used to analyze the association between engagement in the 
patient-provider relationship and perceived quality of life, medication adherence, and adherence 
to provider advice.  
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Results 
Sample 
 A total of 57 subjects were recruited for the study. Ages ranged from 20 to 65 
(mean=40.4, SD=9.7) years and females comprised 28% of the sample. The ethnicity of the 
sample was African American, 35%; Hispanic/Latino, 2%; Native American, 3%; white, 58%; 
and Other, 2%. Average length of HIV diagnosis was 10 years (SD=5.7). Thirty-nine percent of 
the subjects reported having been diagnosed with AIDS. Socio-demographic data are 
summarized in Table 2. 
Engagement with Health Care Provider 
 The mean score was 17.9 (SD=8.4) with a range of 0 to 43, lower scores indicating more 
engagement. Primary health care provider type of the sample was doctor, 93%; and nurse 
practitioner, 7%. Table 3 provides scores from individual constructs and their respective 
measures. 
Relationship Between Engagement with Health Care Provider and Quality of Life 
 The mean score on the HAT-QoL scale was 56.9 (SD=21.1) with scores ranging from 28 
to 119. Higher scores indicate better functioning and quality of life. Improved quality of life was 
significantly related to engagement with health care provider (p=0.013). Correlations are 
presented in Table 4. 
Relationship Between Engagement with Health Care Provider and Adherence to Medications 
 Scores on the 0 to15 medication adherence checklist ranged from 0 to 9, with a mean of 
1.5 (SD=1.9). Lower scores indicate better adherence. While positively correlated, there was no 
evidence of a statistically significant relationship between engagement and adherence to 
medication. 
Relationship Between Engagement with Health Care Provider and Adherence to Provider 
Advice 
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 The mean score on the advice and instruction scale was 6.8 (SD=1.4) with a range of 5 
to 11, lower scores indicating more adherence. Comparisons revealed a significant relationship 
between engagement and adherence to provider advice (p=0.001). 
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Discussion 
 
 In this study of outpatient HIV/AIDS patients, participants who reported a higher level of 
engagement and quality of life, were more likely to be adherent to their provider’s advice. 
Significant relationships between engagement in the patient-provider relationship and quality of 
life and adherence to provider advice were found.  
These results support existing literature suggesting a positive relationship between 
engagement with health care provider and adherence. Notably, Bakken et al. (2000) conducted 
a similar study examining the same variables. Results of that study, too, yielded a significant 
relationship between engagement and adherence to advice and instruction (p<0.001) in a much 
larger sample (n=707). Further, clients in the sample reporting higher scores on the quality of 
life measure also reported more engagement with health care provider, consistent with the 
findings of this study.  
Few previous studies have specifically examined the relationship between engagement 
and quality of life. Respondents in this study reporting high levels of engagement also reported 
improved quality of life. While a standardized measurement to assess quality of life is not 
available, an interplay of psychological, social, and physical factors is involved. Findings of this 
study support the influence of social factors, specifically the role of the patient-provider 
relationship, in quality of life within this population.  
Research examining adherence to therapeutic regimen among persons with HIV/AIDS 
has been extensive, given its direct relationship to disease progression (Holzemer et al., 1999; 
McPherson-Baker et al, 2000; Blaschke, 1997). Correlates of non-adherence identified by 
researchers include the presence of distressing symptoms (Fontaine et al., 1999), treatment-
related symptoms (Melbourne, et al., 1998), and poor quality of life markers (Holzemer et al., 
1999). Results of this study identify an association, although not statistically significant, between 
engagement and adherence to medication. The instrument used to measure adherence in this 
study could have influenced this finding, in that it asks respondents potential reasons they may 
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not take their medication; consequently, it is not measuring adherence directly, but reasons for 
non-adherence.  
A positive relationship between engagement and adherence to provider advice was also 
demonstrated in this study. Thom and Campbell (1997) reported that patients who trusted their 
health care provider were more likely to follow treatment recommendations.  
Implications 
 Findings of this study can be used clinically to improve the interaction between clients 
with HIV/AIDS and their health care providers. The results suggest a strong link between this 
interaction and patient outcomes of quality of life and adherence to therapeutic regimens. 
Awareness of this association should encourage the provider to foster a caring, therapeutic 
relationship with clients to promote positive outcomes. Nurses, particularly, are in an optimal 
position to foster such a therapeutic relationship, as they are intimately involved in patient care. 
Indeed, a study of HIV/AIDS patients found that having a primary nurse was a significant 
predictor of client satisfaction with care (Stone, Weissman, & Cleary, 1995). 
Limitations 
 Limitations of this study included those inherent in the research design used. For 
example, inaccuracies due to poor subject recall can be expected in a self-report design such 
as this. Furthermore, the design poses a potential threat to both internal and external validity. 
Because a convenience sample is being used, respondents are not randomly selected, and, 
therefore may not be representative of all members of the target population. However, 
demographic characteristics of the sample have been reported to provide a better picture of the 
specific population to whom the results are generalizable. Results should be examined in this 
context.  
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Conclusion 
A positive relationship was demonstrated between patient-provider engagement and 
quality of life and adherence behavior among participants in this study. These findings are 
consistent with existing literature and have implications for the development of clinical strategies 
to improve the nature of the patient-provider relationships within the HIV/AIDS population. 
Understanding that this relationship is associated with patient outcomes, such as quality of life 
and adherence, should encourage health care providers to be more conscience and deliberate 
in their interactions with clients to ensure this interaction is perceived positively by the clients. 
Nurses, especially, must understand the holistic nature of the disease in order to realize that 
their therapeutic relationship, in addition to medical interventions, can influence disease 
progression in this population. 
Care of the HIV/AIDS client is multi-faceted, encompassing issues of disease, financial, 
psychological, and social status. Results of this study suggest the need for strategies that foster 
a healthy patient-provider relationship to enhance quality of life and adherence to treatment 
among persons living with HIV/AIDS. Further research is needed in this area to determine 
interventions that will be most successful in reaching these aims.  
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Appendix 
Table 1.  
Overview of Study Variables and Instruments 
Variable and Instruments 
Engagement with health care provider 
     Engagement with Health Care Provider Scale 
 
Demographic characteristics 
     Demographic questionnaire 
          Age 
          Gender 
          Race/ethnicity 
          AIDS diagnosis 
          Length of time known HIV-positive 
 
Quality of life  
     HIV/AIDS Targeted Quality of Life Scale 
          Overall function 
          Life satisfaction 
          Health worries 
          Financial worries 
          Medication worries 
          HIV mastery 
          Disclosure worries 
          Provider trust 
          Sexual function 
 
Adherence 
     Advice and Instruction scale 
     ACTG Reasons for Non-Adherence to  
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Table 2.  
 
Sociodemographic Characteristics of HIV/AIDS Patients in Central Ohio, 2003 (n=57) 
 











































Variable Range Mean SD 
Age (years) 
 

















Table 3.  
 
Scores on Engagement, Quality of Life, Medication Adherence, and Adherence to Provider 
Advice of HIV/AIDS Patients in Central Ohio, 2003 (n=57) 
 
Construct Instrument Number of 
Items 












































































a Lower scores indicate more engagement 
b Higher scores indicate improved quality of life 
c Lower scores indicate better adherence 
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Table 4.  
 
Correlations Between Engagement, Quality of Life, and Adherence Among HIV/AIDS Patients in 
Central Ohio, 2003 (n=57) 
  




ACTG Reasons for Non-
Adherence to Medications 
 







*   Correlation is significant at the 0.05 level 
** Correlation is significant at the 0.01 level 
 
 
 
 
 
